Stirling Anglian PharmaceuticalsStirling Anglian PharmaceuticalsStirling Anglian PharmaceuticalsStirling Anglian Pharmaceuticals
  • Home
  • Our Products
    • Acepiro®
    • theiCal-D3®
    • Stirlescent®
    • CosmoCol®
    • CosmoCol Half®
    • CosmoCol Paediatric®
    • Diclofenac Sodium 3% Gel
    • Calcipotriol 0.005% / Betamethasone Dipropionate 0.05% Gel
  • Corporate Responsibility
    • Patient Safety
    • Transparency Disclosures
    • Social Responsibility
    • Modern Slavery Statement
    • Equality, Diversity & Inclusion
    • Corporate Policies
  • Sustainability
  • Partners
  • Contact
✕

Diclofenac sodium 3% gel

Information for Patients

  • Diclofenac sodium 3% gel - Patient Information Leaflet
  • Diclofenac sodium 3% gel - Summary of Product Characteristics
Information For Healthcare Professionals
Diclofenac sodium 3% gel​​

Patient links and organisations

  • Actinic Keratosis Support Group
  • Patient Support Groups
  • British Association of Dermatologists - Patient Information Leaflets
© 2026 Stirling Anglian Pharmaceuticals Ltd
Registered in Scotland. Company No. SC453258
26-SAP-007 v1.0 - April 2026
Terms & Conditions | Privacy Policy
Website by
Website by
Diclofenac Sodium 3% Gel – Information for Patients
This website uses cookies to improve your experience.
Privacy Policy

Information for Healthcare Professionals

The information on this page is intended for healthcare professionals only.

You are leaving our website

The link you have requested is on an external website.

Continue Cancel